Handok Pharma receives Frost & Sullivan awards

Published: 2011-01-03 06:56:00

Updated: 2011-01-03 06:56:00

Handok Pharmaceutical Co. says it has been named the 2010 Asia Pacific Frost & Sullivan Diabetes Therapeutics Company of the Year Award by the consulting firm Frost & Sullivan in recognition of its strategic initiatives to strength the position of Amaryl groups at home and abroad.

Frost & Sull...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK